nor-Binaltorphimine dihydrochloride: Selective κ-Opioid Receptor Antagonist for Advanced Receptor Signaling Studies

Executive Summary. nor-Binaltorphimine dihydrochloride is a potent, selective antagonist of the κ-opioid receptor (KOR), primarily utilized for receptor signaling research and opioid receptor subtype analysis (Huo et al., 2023). The compound has a well-defined molecular weight of 734.72 and a chemical formula of C40H43N3O6·2HCl, and it is supplied as an off-white solid for research use only (APExBIO). With verified solubility of <18.37 mg/mL in DMSO and optimal storage at -20°C, nor-Binaltorphimine dihydrochloride ensures experimental reproducibility. Its selectivity enables the dissection of κ-opioid receptor-mediated signal transduction in pain modulation, mood regulation, and addiction studies (site ref). Recent circuit-level studies validate its role in mapping neural pathways underlying mechanical allodynia and opioid signaling (DOI).

Biological Rationale

The κ-opioid receptor (KOR) is a G protein-coupled receptor (GPCR) expressed in both central and peripheral nervous systems. KORs are involved in pain modulation, mood regulation, stress response, and addiction mechanisms (Huo et al., 2023). Selective antagonists like nor-Binaltorphimine dihydrochloride are pivotal for dissecting KOR-specific pathways, distinguishing them from μ- and δ-opioid receptors in receptor subtype analysis. Dysregulation of KOR signaling is implicated in chronic pain syndromes, depression, and substance use disorders. The ability to selectively inhibit KOR enables researchers to map circuit-level effects and downstream signaling cascades.

Mechanism of Action of nor-Binaltorphimine dihydrochloride

nor-Binaltorphimine dihydrochloride binds selectively and with high affinity to the κ-opioid receptor, acting as a competitive antagonist. It blocks endogenous and exogenous KOR agonists, disrupting receptor-mediated G protein signaling. The compound does not appreciably interact with μ- or δ-opioid receptors at standard experimental concentrations (<1 μM), supporting its use in subtype-specific studies (site ref). Structural specificity is conferred by its tetradecahydro-dibenzofuro-dipyrido-carbazole scaffold, which aligns with the KOR ligand-binding pocket. The dihydrochloride salt improves solubility and handling for in vitro and in vivo assays. Its pharmacokinetic profile supports sustained receptor occupancy, enabling both acute and chronic research paradigms.

Evidence & Benchmarks

• nor-Binaltorphimine dihydrochloride administration (10 mg/kg, i.p.) in mice robustly blocks spinal KORs, resulting in persistent bilateral mechanical allodynia, confirming KOR's inhibitory role in pain modulation (Huo et al., 2023).
• Selective antagonism by nor-Binaltorphimine dihydrochloride enables mapping of descending brain-to-spinal circuits regulating pain laterality and duration, which is not achievable with non-selective antagonists (DOI).
• The compound exhibits <18.37 mg/mL solubility in DMSO at room temperature and is stable for >6 months at -20°C (APExBIO).
• Benchmark studies confirm no significant inhibition of μ- or δ-opioid receptor-mediated signaling at concentrations up to 1 μM (site ref).
• Integration of nor-Binaltorphimine dihydrochloride in receptor antagonist assays improves reproducibility and minimizes off-target effects compared to earlier generations of KOR antagonists (site ref).

Applications, Limits & Misconceptions

nor-Binaltorphimine dihydrochloride is a cornerstone in opioid receptor signaling research, receptor antagonist assays, and circuit-mapping studies. Applications include:

• Pain modulation research: Dissection of KOR-mediated inhibitory circuits in chronic and neuropathic pain models.
• Addiction and dependence studies: Investigation of KOR's role in drug reward and aversion pathways.
• Mood regulation research: Analysis of KOR signaling in depression and anxiety models.
• Opioid receptor subtype analysis: Distinguishing KOR signaling from μ- and δ-opioid effects.
• Pharmacological validation of receptor-specific interventions in translational neuroscience (site ref).

This article extends prior summaries such as nor-Binaltorphimine Dihydrochloride: Selective κ-Opioid R... by integrating the latest circuit-level evidence and providing updated benchmarks for solubility, specificity, and protocol reproducibility.

Common Pitfalls or Misconceptions

• Not a diagnostic or therapeutic agent: nor-Binaltorphimine dihydrochloride is strictly for research use; it is not approved for clinical or diagnostic applications (APExBIO).
• Limited solubility: Exceeding 18.37 mg/mL in DMSO can cause precipitation and loss of activity.
• Not effective in non-KOR systems: The compound does not block μ- or δ-opioid receptors at standard research concentrations.
• Storage at -20°C required: Deviations from recommended storage reduce stability and potency.
• Species differences: KOR distribution and pharmacodynamics may vary between rodent and human tissues; extrapolation requires caution.

Workflow Integration & Parameters

nor-Binaltorphimine dihydrochloride (APExBIO SKU B6269) is supplied as an off-white solid and should be aliquoted and stored at -20°C for long-term use. For in vitro applications, dissolve in DMSO up to the solubility threshold of 18.37 mg/mL. For in vivo studies, prepare dosing solutions shortly before administration to maintain activity. The product is shipped with blue ice to ensure integrity. Recommended working concentrations range from 10 nM to 1 μM for cell assays and 1–10 mg/kg for animal models, as validated in published protocols (Huo et al., 2023). Adherence to these parameters ensures reproducibility and minimizes batch-to-batch variability.

For additional scenario-driven guidance on protocol optimization and data integrity, see Solving Laboratory Challenges with nor-Binaltorphimine di.... This article builds on their Q&A approach by providing updated best practices for antagonist assays and circuit mapping.

Researchers seeking product availability and full specifications can access the product page for nor-Binaltorphimine dihydrochloride (B6269).

Conclusion & Outlook

nor-Binaltorphimine dihydrochloride is an essential research chemical for selective kappa opioid receptor antagonist assays and opioid receptor pharmacology. Its high specificity, validated performance in receptor signaling studies, and robust handling parameters make it indispensable for neuroscience, pain modulation, and addiction mechanism research. Ongoing neural circuit studies and translational models continue to extend the application landscape for this compound. As new evidence emerges, nor-Binaltorphimine dihydrochloride will remain a critical standard for dissecting κ-opioid receptor pathways, with APExBIO providing consistent quality and technical validation.